Orchard Therapeutics PLC
Neetu Chatterjee, PhD currently holds the position of Senior Manager, GMP QA Global Quality at Orchard Therapeutics. Prior to this, Neetu held various quality assurance roles at Lonza, WILCARE PHARMA LIMITED, Merck Serono, and Johnson & Johnson. Neetu took a career break from 2011 to 2013 due to relocation and childcare responsibilities. Neetu's education includes a PhD in Organic Chemistry from the University of Leeds and QP training from UCL.
This person is not in the org chart
Orchard Therapeutics PLC
3 followers
Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.